Diabetic Cardiomyopathies
Diabetic Cardiomyopathies
Explore linked clinical trials. Standard reference: MESH:M054068310 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications | Arrhythmias, Cardiac, Arterial Occlusive Diseases, Diabetes Complications, Diabetic Cardiomyopathies, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, cardiomyopathy, cardiovascular disorder, coronary artery disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, metabolic disease, myocardial ischemia, type 2 diabetes mellitus, vascular disorder | Not yet recruiting | Not stated | 2026-09-29 | NCT07847112 | |
| NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study | Diabetes Complications, Diabetic Cardiomyopathies, Nutritional and Metabolic Diseases, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, metabolic disease, type 2 diabetes mellitus | Recruiting | Not applicable | 2026-09-29 | NCT06593327 | |
| Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes | Diabetes Complications, Diabetic Cardiomyopathies, Nutritional and Metabolic Diseases, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, metabolic disease, type 2 diabetes mellitus | Not yet recruiting | Not stated | 2026-08-18 | NCT07770737 | |
| Polypill for Prevention of Cardiomyopathy | Diabetes Complications, Diabetic Cardiomyopathies, Nutritional and Metabolic Diseases, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, hypertensive disorder, metabolic disease, type 2 diabetes mellitus, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-04 | NCT06143566 | |
| CARdiomyopathy in Type 2 DIAbetes Mellitus | Diabetes Complications, Diabetic Cardiomyopathies, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, heart disorder | Active, not recruiting | Not stated | 2026-05-06 | NCT04303364 | |
| Mitochondrial Substrate Utilization in the Diabetic Human Heart | Diabetes Complications, Diabetic Cardiomyopathies, Insulin Resistance, Nutritional and Metabolic Diseases, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, heart failure, hyperinsulinism, inborn mitochondrial metabolism disorder, metabolic disease, type 2 diabetes mellitus | Recruiting | Not stated | 2026-02-19 | NCT05958706 | |
| Tailored Exercise Training Study Among Adults With HFpEF | Body Weight, Body Weight Changes, Diabetes Complications, Diabetic Cardiomyopathies, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, heart disorder | Recruiting | Phase 2 / Phase 3 | 2025-10-31 | NCT07223242 | |
| Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus | Diabetes Complications, Diabetic Cardiomyopathies, Nutritional and Metabolic Diseases, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, metabolic disease, type 2 diabetes mellitus | Recruiting | Not stated | 2024-01-05 | NCT03132129 | |
| CMR in T2DM: The NSR Cohort | Diabetes Complications, Diabetic Cardiomyopathies, Fibrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, metabolic disease, type 2 diabetes mellitus | Enrolling by invitation | Not stated | 2023-06-22 | NCT05915260 | |
| Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy | Diabetes Complications, Diabetic Cardiomyopathies, Nutritional and Metabolic Diseases, cardiomyopathy, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Phase 3 | 2022-12-08 | NCT04083339 |